401
edits
Heart Failure: Difference between revisions
Jump to navigation
Jump to search
→β-Blockers
| Line 264: | Line 264: | ||
Aldosterone antagonists | Aldosterone antagonists | ||
Adding this drug to therapy is suggested for patients with severe symptomatic (NYHA class III or IV, refer to | Adding this drug to therapy is suggested for patients with severe symptomatic (NYHA class III or IV, refer to Table 2) HF and an LVEF < 35%. (Class I recommendation, level of evidence B) Contraindications: | ||
* Serum potassium concentration > 5.0 mmol/L | * Serum potassium concentration > 5.0 mmol/L | ||
* Serum creatine > 220 µmol/L | * Serum creatine > 220 µmol/L | ||